TEVA

Teva Pharmaceutical Industries LimitedNYSEHealthcare

$30.08-0.56%ClosedMarket Cap: $35.03B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-04	Piper Sandler	—	Overweight	—
2026-02-18	Truist Securities	—	Buy	—
2026-02-09	Goldman Sachs	—	Buy	—
2026-01-30	Barclays	—	Overweight	—
2026-01-29	Scotiabank	—	Sector Outperform	—
2026-01-06	Jefferies	—	Buy	—
2025-12-22	Piper Sandler	—	Overweight	—
2025-12-19	Goldman Sachs	—	Buy	—
2025-12-16	JP Morgan	—	Overweight	—
2025-12-09	B of A Securities	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$3.09	$17.14B	8
Sun Dec 31	$3.41	$17.84B	3
Mon Dec 31	$3.56	$18.11B	1
Tue Dec 31	$4.02	$18.94B	1